Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. As the crisis rages on, modern experts are calling for a serious intervention—an intervention like legal cannabis. Interestingly, although opioids work well for acute pain (e.g.,

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 106

Research and Development Consumption Education Data 106

Cannabis Law Report

JUNE 30, 2021

s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The full ASCO meeting program is available at: www.asco.org. NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. About AIkido Pharma Inc.

Data 100

Data Research and Development Clinical Trials Therapy 100

NORML

JANUARY 28, 2020

Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. In 2018 there were nearly 24,000 adults arrested for less than 30 grams of cannabis. cannabis arrest data since 2008.

Marijuana 288

Marijuana Data Decriminalization Policy 288

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

SEPTEMBER 17, 2021

HARRISBURG — The public could soon know for the first time how many patients use medical marijuana to treat opioid use disorder in Pennsylvania, one of the few states to specifically endorse that treatment option. Cordeiro died of an overdose a few weeks later.

Treatment 52

Treatment Patients Data Policy 52

Project CBD

JUNE 20, 2023

Pain, anxiety, and sleep are major drivers of medical cannabis use. 1 Even small doses of cannabis can soothe the stomach and stimulate the appetite. In fact, of the four cannabis-derived drugs approved so far by the U.S. Even small doses of cannabis can soothe the stomach and stimulate the appetite.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

SpeedWeed

JANUARY 25, 2019

Prescription painkiller addicts can now seek medical cannabis as a form of treatment in New Jersey. The state will also eliminate a prior authorization requirement for Medicaid recipients to receive medication-assisted treatment (MAT). 20, averaging nearly 7 deaths per day. “To be determined.” Oscar Pascual.

Treatment 65

Treatment Marijuana Conditions Data 65

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Why Do MMJ Patients Use Cannabis? How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

SpeedWeed

APRIL 8, 2021

Advocates are calling New York’s legal marijuana program the best in the nation. How Great is New York’s New Legal Cannabis Program? . First of all, possession by adults of up to three ounces of cannabis and 24 grams of concentrate is legal, effective immediately. . Let me count the ways. Automatic expungement.

Programs 52

Programs Legalization Consumption Cannabis 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects.

Data 52

Data Patients Access Wellness and Beauty 52

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 240

Chronic Pain Therapy Patients Topical 240

Cannabis Law Report

DECEMBER 7, 2021

Ibogaine is not the ideal addiction-treatment drug; it can cause cardiac arrhythmia (an irregular heartbeat) and its intense psychedelic experience is not for everyone. All testing is conducted under blinded conditions and all data is confidential. We’re particularly excited about this as a possibility,” says Compton.

Treatment 52

Treatment Clinical Trials Data Conditions 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 247

Clinical Trials Chronic Pain Cannabinoids Patients 247

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. A sample of 120 patients aged between 5 and 29 years old with mild to severe autism are currently being given two different cannabis oil formulas or placebo. The Current Treatments for Autism. Instead, CBD is being used.

Treatment 76

Treatment Oil CBD Therapy 76

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

SpeedWeed

MAY 28, 2021

New Hampshire will now be expanding the pool of patients eligible to receive medical cannabis, thanks to a newly signed bill, HB 89. Under this new law, physicians will be allowed to authorize patients who have moderate or severe insomnia to use medical cannabis. The ratio they used was 30 percent CBD and 1.5

Programs 52

Programs Research and Development Patients Safety 52

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. CUD and adult cannabis use prevalence were determined over the course of the last 12 months.

Consumption 97

Consumption Research and Development Treatment Programs 97

Veriheal

AUGUST 31, 2021

At Veriheal, a minority-owned medical marijuana platform, we’re invested in paying it forward in the cannabis industry. That’s why we started the Veriheal Innovation in Cannabis Scholarship last year. This year, we are happy to announce we are expanding our scholarship program and awarding $20,0000 in scholarships to 20 winners. .

Research and Development 116

Research and Development Supply Chain Programs Education 116

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Peninsula Alternative Health

MARCH 1, 2018

Advocating for medical cannabis is no easy feat, and these organizations are spearheading state, national, and global efforts. The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients.

Treatment 40

Treatment Education Advocacy Access 40

Cannabis Law Report

SEPTEMBER 1, 2022

exas’ leading medical cannabis provider is highlighting the medicine’s efficacy in pain management therapies during Pain Awareness Month. Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact. found cannabis much more effective than their prescription. of cannabis patients.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Peninsula Alternative Health

MARCH 1, 2018

Advocating for medical cannabis is no easy feat, and these organizations are spearheading state, national, and global efforts. The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients.

Treatment 40

Treatment Education Advocacy Access 40

Veriheal

JANUARY 10, 2022

Of this amount, as many as 43,600 sufferers will eventually lose their lives despite undergoing treatment for the disease and its debilitating symptoms. Conventional methods of treatment for breast cancer—including chemotherapy—are known for causing a plethora of unwanted side effects. Breast Cancer Patients and Medical Cannabis.

Patients 98

Patients Treatment Medicine Consumption 98

NORML

JANUARY 28, 2019

A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013. Cannabis reform has stalled recently because of opposition from Kentucky’s Senate leadership. Danny Bentley, R-Russell, erroneously compared cannabis to “snake oil remedies of the 1800s,” according to a WDRB-TV report.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

MedicalJane

DECEMBER 13, 2017

Introduced in July 2014, New York’s medical marijuana program has been a work in progress from the get-go. The state recently announced an expansion to its program that is beginning to open the door to improved patient access. These changes included adding chronic pain and PTSD to its list of qualifying medical conditions.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

The Cannigma

MARCH 2, 2021

Many US military veterans avoid speaking to a doctor before self-medicating with cannabis due to stigma and fear of consequences, potentially putting their health at risk, according to the findings of a new study. Reddit and the anonymity to talk about cannabis. What are veterans using medical cannabis for? Shutterstock).

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

JUNE 16, 2021

As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85